Wordt geladen...
Global Manufacturing of CAR T Cell Therapy
Immunotherapy using chimeric antigen receptor-modified T cells has demonstrated high response rates in patients with B cell malignancies, and chimeric antigen receptor T cell therapy is now being investigated in several hematologic and solid tumor types. Chimeric antigen receptor T cells are generat...
Bewaard in:
Gepubliceerd in: | Mol Ther Methods Clin Dev |
---|---|
Hoofdauteurs: | , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
American Society of Gene & Cell Therapy
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363291/ https://ncbi.nlm.nih.gov/pubmed/28344995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2016.12.006 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|